SCOR holds its course: combining growth, profitability and solvency to record a net result of EUR 330 million in 2011.
- FR
- EN
SCOR holds its course: combining growth, profitability and solvency to record a net result of EUR 330 million in 2011.
SCOR holds its course: combining growth, profitability and solvency to record a net result of EUR 330 million in 2011.
Kidney donation is becoming increasingly common throughout the world, with the United States and Japan leading the way in this field, and the studies referenced in this Newsletter came from these two countries.
Kidney donation is becoming increasingly common throughout the world, with the United States and Japan leading the way in this field, and the studies referenced in this Newsletter came from these two countries.
Kidney donation is becoming increasingly common throughout the world, with the United States and Japan leading the way in this field, and the studies referenced in this Newsletter came from these two countries.
SCOR Global P&C has recorded a very satisfactory increase in its business in 2011: gross written premiums are up by 8.8% to EUR 3.982 billion at current exchange rates.
Life insurers are cautious about integrating medical and technological advances into their underwriting procedures in order to avoid unintended consequences to decision accuracy.
In my role as a Research Actuary, I am often asked to perform mortality experience studies using the SOA 2001 Valuation Basic Tables (VBT) as an expected basis.
The Continuous Mortality Investigation (CMI) has recently published Working Papers 52 and 58. These Papers represent a third phase in the activity of the CMI Critical Illness Committee.
PDF File
PDF File
PDF File
Pagination